VRBPAC Meeting – Rebiotix Indication for Recurrent Clostridioides difficile Infection
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene on 22 September 2022 to discuss the Biologics License Application # 125739 (BLA - 125739) from Rebiotix Inc. for